Giant Cell Reparative Granuloma, a rare benign bone tumor in a child: case report
DOI:
https://doi.org/10.47456/rbps.v23isupl_1.36623Keywords:
Giant Cell Granuloma, Jaw, Maxillomandibular neoplasmsAbstract
Introduction: Giant Cell Reconstructive Granuloma (GCRG) is a rare and benign intraosseous tumor. It is unilateral and affects the mandible in the vast majority of cases, with variable clinical presentation resulting from tumor expansion. It has a good prognosis and there are no reports of metastatic lesions. Case report: A case study of a 6-year-old male, without comorbidities, with a rapidly growing bilateral tumor in the mandible (SIC). Hardened, painless lesion, without phlogistic signs, with bulging of the cheek mucosa and protuberances on the gingiva. He denied fever, weight loss, other symptoms or local trauma. Laboratory tests, serology, CT scans of the cervical, chest, abdomen and pelvis without alterations. Face tomography: expansive lesion remodeling the mandible with areas of continuity solution in the cortical bone, suggestive of fibrous dysplasia. Biopsy was performed showing GRCG. The GCRG corresponds to 7% of mandibular and maxillary tumors, of not yet fully defined etiology, usually observed after trauma and local inflammation, described as a reparative process resulting from possible intraosseous hemorrhage. More frequent in children and young adults, the clinic comes from intraosseous tumor expansion: compressive effects, facial asymmetry and dental deformities. Differential diagnoses include: giant cell tumor (GCT), aneurysmal bone cyst, fibrous dysplasia and the brown tumor. Its main differential diagnosis is GCT, a malignant tumor. Conclusion: Imaging exams help in the initial approach and the definitive diagnosis is through anatomic/histological study. The treatment of choice is surgical with low recurrence, usually attributed to incomplete resection.
Downloads
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Revista Brasileira de Pesquisa em Saúde/Brazilian Journal of Health Research

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
The Revista Brasileira de Pesquisa em Saúde (RBPS) adopts the CC BY 4.0 license, which means that authors retain the copyright of the works they submit to the journal. Authors are responsible for declaring that their contribution is an original manuscript, that it has not been previously published, and that it is not under simultaneous review by another scientific journal. Upon submitting the manuscript, authors grant RBPS the exclusive right of first publication, subject to peer review.
Authors are permitted to enter into additional contracts for the non-exclusive distribution of the version published by RBPS (for example, in institutional repositories or as a book chapter), provided that due acknowledgment of authorship and of initial publication by RBPS is given. Authors are also encouraged to make their work available online (for example, in institutional repositories or on their personal pages) after its initial publication in the journal, with due acknowledgment of authorship and of the original publication by RBPS.
Accordingly, under the CC BY 4.0 license, readers have the right to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially;
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
The licensor cannot revoke these freedoms as long as you follow the license terms. Under the following terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.